Fresh Tracks Therapeutics Inc. (FRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fresh Tracks Therapeutics...

    NASDAQ: FRTX · Real-Time Price · USD
    0.94
    0.00 (0.00%)
    At close: Feb 28, 2025, 12:19 PM

    Fresh Tracks Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 10.87M 8.68M 26.88M
    Short-Term Investments
    		 n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 n/a -1.41M -117K
    Receivables
    		 45K 504K 125K
    Inventory
    		 n/a -504K -125K
    Other Current Assets
    		 94K 124K 59K
    Total Current Assets
    		 11.55M 10.08M 29.6M
    Property-Plant & Equipment
    		 34K 124K 117K
    Goodwill & Intangibles
    		 n/a 1.47M n/a
    Total Long-Term Assets
    		 34K 188K 117K
    Total Assets
    		 11.59M 10.27M 29.72M
    Account Payables
    		 406K 571K 1.6M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a
    Other Current Liabilities
    		 1.25M 1.32M 1.86M
    Total Current Liabilities
    		 1.66M 3.08M 4.81M
    Long-Term Debt
    		 n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a 620K n/a
    Total Liabilities
    		 1.66M 3.08M 4.81M
    Total Debt
    		 n/a 49K 69K
    Book Value
    		 9.93M 7.19M 24.91M
    Book Value Per Share
    		 1.68 2.56 13.96
    Common Stock
    		 60K 30K 1.19M
    Retained Earnings
    		 -172.16M -166.47M -145.37M
    Comprehensive Income
    		 n/a n/a n/a
    Shareholders Equity
    		 9.93M 7.19M 24.91M
    Total Investments
    		 n/a n/a n/a

    Add to Watchlist